Form 8-K - Current report:
SEC Accession No. 0000950170-25-088752
Filing Date
2025-06-23
Accepted
2025-06-23 10:10:46
Documents
11
Period of Report
2025-06-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sana-20250623.htm   iXBRL 8-K 55183
2 EX-99.1 sana-ex99_1.htm EX-99.1 31627
  Complete submission text file 0000950170-25-088752.txt   212226

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sana-20250623.xsd EX-101.SCH 31892
13 EXTRACTED XBRL INSTANCE DOCUMENT sana-20250623_htm.xml XML 4893
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 251063317
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)